Mainz Biomed B.V. (MYNZ)
USD 3.78
(-14.48%)
USD 3.78
(-14.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -21.93 Million | -14.76 Million | -3.22 Million | -468.73 Thousand | -416.49 Thousand |
| Net Income | -26.29 Million | -26.38 Million | -11.69 Million | -586.89 Thousand | -957.05 Thousand |
| Depreciation & Amortization | 866.41 Thousand | 379.79 Thousand | 69.92 Thousand | 60.46 Thousand | 53.04 Thousand |
| Deferred income taxes | 42.36 Thousand | - | - | - | - |
| Stock-based compensation | 4 Million | 9.82 Million | 6.43 Million | - | - |
| Change in working capital | -64.63 Thousand | 1.38 Million | -138.61 Thousand | 57.58 Thousand | 423.03 Thousand |
| Other non-cash items | -492.89 Thousand | 26.78 Thousand | 2.1 Million | 107.00 | 64.48 Thousand |
| Investing Cash Flow | -1.89 Million | -658.48 Thousand | 1.2 Million | -9685.00 | - |
| Investments in PPE | -1.89 Million | -658.48 Thousand | -16.7 Thousand | -9685.00 | - |
| Acquisitions | - | - | 1.21 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -700 Thousand | - | 1.21 Million | - | - |
| Financing Cash Flow | 14.22 Million | 23.94 Million | 10.61 Million | 396.68 Thousand | 423.99 Thousand |
| Debt repayment | -2.28 Million | -304.97 Thousand | -61.24 Thousand | -38.87 Thousand | -30.41 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 6.39 Million | 23.86 Million | 10.42 Million | - | - |
| Other Financing Activities | -933.75 Thousand | 382.5 Thousand | 246.61 Thousand | 435.55 Thousand | 454.4 Thousand |
| Accounts receivables | 15.54 Thousand | -211.23 Thousand | 24.21 Thousand | -99.15 Thousand | 339.62 Thousand |
| Accounts payables | 720.23 Thousand | 1.82 Billion | 670.72 Million | 160.47 Thousand | - |
| Inventory | -500.18 Thousand | -172.37 Thousand | -670.72 Million | -160.47 Thousand | - |
| Other working capital | -300.22 Thousand | -1.82 Billion | -162.83 Thousand | 156.74 Thousand | 83.41 Thousand |
| Cash at beginning of period | 17.14 Million | 8.72 Million | 122.56 Thousand | 203.58 Thousand | 229.53 Thousand |
| Cash at end of period | 7.07 Million | 17.14 Million | 8.72 Million | 122.56 Thousand | 203.58 Thousand |
| Capital Expenditure | -1.89 Million | -658.48 Thousand | -16.7 Thousand | -9685.00 | - |
| Effect of forex changes on cash | -459.85 Thousand | -101.11 Thousand | 11.61 Thousand | 721.00 | -33.44 Thousand |
| Net cash flow / Change in cash | -10.07 Million | 8.41 Million | 8.6 Million | -81.02 Thousand | -25.94 Thousand |
| Free Cash Flow | -23.83 Million | -15.42 Million | -3.23 Million | -478.42 Thousand | -416.49 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.18 Million | -26.29 Million | -6.29 Million | -8.25 Million | -6.56 Million | -26.38 Million |
| Depreciation & Amortization | 204.47 Thousand | 866.41 Thousand | 203.57 Thousand | 171.01 Thousand | 287.35 Thousand | 379.79 Thousand |
| Deferred income taxes | -17.54 Thousand | 42.36 Thousand | 6611.00 | -1.00 | - | - |
| Stock-based compensation | 818.99 Thousand | 4 Million | 1.09 Million | 2.09 Million | 919.42 Thousand | 9.82 Million |
| Change in working capital | 235.07 Thousand | -64.63 Thousand | -1.68 Million | 1.78 Million | -397.55 Thousand | 1.38 Million |
| Other non-cash items | -712.85 Thousand | -492.89 Thousand | 176.2 Thousand | 4756.00 | 92.29 Thousand | 26.78 Thousand |
| Investing Cash Flow | -261.8 Thousand | -1.89 Million | -112.47 Thousand | -123.62 Thousand | -1.4 Million | -658.48 Thousand |
| Investments in PPE | -261.8 Thousand | -1.89 Million | -112.47 Thousand | -123.62 Thousand | -1.4 Million | -658.48 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -200 Thousand | -700 Thousand | - | -500 Thousand | - | - |
| Financing Cash Flow | 3.46 Million | 14.22 Million | 4.56 Million | 5.41 Million | 773.48 Thousand | 23.94 Million |
| Debt repayment | -1.96 Million | -2.28 Million | -444.79 Thousand | -670.96 Thousand | -91.27 Thousand | -304.97 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -418.62 Thousand | - |
| Common Stock Issuance | 4.49 Million | 6.39 Million | -1546.00 | 611.35 Thousand | 1.28 Million | 23.86 Million |
| Other Financing Activities | 1123.00 | -933.75 Thousand | 5.01 Million | 5.47 Million | -418.62 Thousand | 382.5 Thousand |
| Accounts receivables | 101.23 Thousand | 15.54 Thousand | -144.58 Thousand | 58.89 Thousand | 27.66 Thousand | -211.23 Thousand |
| Accounts payables | 484.67 Thousand | 720.23 Thousand | -925.94 Thousand | -58.89 Thousand | -390.16 Thousand | 1.82 Billion |
| Inventory | -158.13 Thousand | -500.18 Thousand | -133.68 Thousand | -121.05 Thousand | -87.31 Thousand | -172.37 Thousand |
| Other working capital | -192.69 Thousand | -300.22 Thousand | -478.21 Thousand | 1.9 Million | 52.26 Thousand | -1.82 Billion |
| Cash at beginning of period | 9.32 Million | 17.14 Million | 10.91 Million | 10.85 Million | 17.14 Million | 8.72 Million |
| Cash at end of period | 7.07 Million | 7.07 Million | 9.32 Million | 10.91 Million | 10.85 Million | 17.14 Million |
| Capital Expenditure | -261.8 Thousand | -1.89 Million | -112.47 Thousand | -123.62 Thousand | -1.4 Million | -658.48 Thousand |
| Effect of forex changes on cash | -798.26 Thousand | -459.85 Thousand | 458.92 Thousand | -123.77 Thousand | 3264.00 | -101.11 Thousand |
| Net cash flow / Change in cash | -2.24 Million | -10.07 Million | -1.59 Million | 52.88 Thousand | -6.28 Million | 8.41 Million |
| Free Cash Flow | -4.91 Million | -23.83 Million | -6.61 Million | -5.24 Million | -7.06 Million | -15.42 Million |
ESAU
000670
GLOSTERLTD
RVTI
SRTOY
6879